Advertisement

Related Videos

Peter Clark, MA, MD, FRCP: A Payer Perspective

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Amit Sanyal, MD: A Clinician’s Perspective

Advertisement

Advertisement




Mar
14
Today In Oncology
Female Reproductive Cancers Linked to Reduced Survival Advantage Over Males
p53 Reactivator Rezatapopt in TP53 Y220C–Mutated Solid Tumors
BCMA CAR T-Cell Therapy in Newly Diagnosed Multiple Myeloma
Disease Stage at Breast Cancer Diagnosis Impacted by Region Race and Insurance
Can Viral Respiratory Infections Increase Lung Cancer Risk
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo